99% Weight Loss Mazdutide Peptide Powder ibi362 cas 2259884-03-0
TDS 5 Inquiries
2259884-03-0
Top Product
98%
Wuhan
Senwayer
10mg/box
Yes
2027-03-11
API,nutrition supplements,plant extract,peptide,HCG,6-Aminocaproic acid
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial Reference
Mazdutide is a peptide-based GLP-1 and glucagon receptor (GCGR) dual agonist. As a pharmaceutical raw material, Mazdutide is characterized by its dual receptor activity and defined peptide structure. It is suitable for API research, analytical testing, pharmaceutical development, and related manufacturing processes.
Certificates-
TDS
Basic Info-
Product Name:
Mazdutide
Other Name:Mazdutide;Mazdutide acetate;Mazdutide 10mg;Mazdutide 5mg 10mg;LY-3305677;Mazdutide (IBI-362;OXM-3)
CAS No.:2259884-03-0
Molecular Weight:0
EC Number:884-103-0
Color/Form:White to off-white
Categories:
Research-
Class:
Dual GLP-1R/GCGR agonist (long-acting peptide)
Status:Investigational — Phase 3 (China)
Mechanism:A long-acting dual agonist of the GLP-1 receptor (GLP-1R, Ki = 28.6 nM) and glucagon receptor (GCGR, Ki = 17.7 nM). The dual activation provides both glycemic control (via GLP-1R) and increased energy expenditure / hepatic lipolysis (via GCGR), producing weight loss beyond what GLP-1R agonism alone achieves.
EC50 (GLP1R Ki):28.6 nM
EC50 (GCGR Ki):17.7 nM
Source:GlpBio: Mazdutide (CAS 2259884-03-0); Innovent Phase Ib results (eClinicalMedicine 2022).DOI
Clinical Development:
References-
PubChem:Literature:
GlpBio: Mazdutide (CAS 2259884-03-0); eClinicalMedicine: Innovent Phase Ib results (2022); ClinicalTrials.gov: DREAMS-1 (NCT04930343)
Disclaimer:Mazdutide is NOT FDA-approved or EMA-approved. It is in Phase 3 clinical trials in China. This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
API,nutrition supplements,plant extract,peptide,HCG,6-Aminocaproic acid
-
Location:
Room 707, Block A, Zhongxing Times Digital Trade Port, No. 79 Xudong Street, Hongshan District, Wuhan City
-
Payment Terms:
TT against copy of documents,L/C
-
Average lead Time:
10 days
-
Total Annual Revenue:
$2.5 million-$5 million
-
Total Employees:
51-100
-
Year of Establishment:
2020
Company Certificates-
Verified supplier certificate
-
SGS
-
-
Inquiry History5 Inquiries
Country Product Purchase Quantity Date Posted
United States
Mazdutide
25 MG Aug 12, 2026
Nigeria
Mazdutide 10mg
20 PCS Mar 7, 2026
United States
Mazdutide
30 MG Jul 15, 2024
United Kingdom
Mazdutide
1 KG Feb 10, 2026
United States
Mazddultide cas
2 MT Nov 14, 2025 Post an enquiry for this product
More from this Seller
-
-
-
MCT OIL 98% Liquid 111-62-6 Senwayer
Top Product / 98%
-
-
-
-
((5-Thiazolyl)methyl)-(4-nitrophenyl)carbonate 99% powder C11H8N2O5S Senwayer
Pharmaceutical Grade / 99%
-
-
-
-
LIGNIN, ORGANOSOLV 99% 8068-03-9 brown powder Senwayer
Pharmaceutical Grade / 99%
-








